Related Experiment Video
Updated: Aug 18, 2026
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Establishment of stroke treatment plans: one hospital's experience
1Winthrop University Hospital, Division of Neurology, 200 Old Country Road, Suite 125, Mineola, NY 11501, USA.
Insights
Stroke care needs improvement, with only 20-30% of hospitals having stroke teams. Educating the public and healthcare professionals on stroke management is crucial for better patient outcomes.
Area of Science:
- Neurology
- Public Health
Background:
- Stroke is a leading cause of death and disability in the US, affecting 700,000 annually.
- The economic burden of stroke exceeds $40 billion yearly.
- Recombinant tissue-type plasminogen activator (t-PA) has improved acute stroke care pathways.
Purpose of the Study:
- To highlight the critical need for enhanced public and healthcare provider education regarding stroke care.
- To address the deficiency in hospital stroke team implementation.
- To advocate for the approval of additional stroke treatment agents, such as neuroprotective medications.
Main Methods:
- Review of current stroke statistics and treatment modalities.
- Analysis of hospital preparedness for acute stroke management.
- Identification of gaps in stroke care protocols and treatment options.
Main Results:
- Only 20-30% of US hospitals have dedicated stroke teams.
- Significant gaps exist in public and healthcare professional education on stroke.
- Limited availability of advanced treatment agents like neuroprotective medications.
Conclusions:
- Urgent improvement in stroke care is necessary, focusing on education and infrastructure.
- Increased implementation of hospital stroke teams is essential.
- Further research and approval of novel stroke therapies are required.
Abstract:
Stroke remains one of the major causes of death and permanent disability in the United States, ranking as the third leading cause of death behind heart disease and cancer. It affects an estimated 700,000 persons each year; about two-thirds of those with a new or recurrent stroke survive. The aggregate cost of stroke in the United States is more than $40 billion per year, with an average cost per case of approximately $50,000. With the advent of recombinant tissue-type plasminogen activator (t-PA) for acute stroke, clinical pathways have been developed to provide efficient care to acute stroke patients. Efforts must be aimed at educating the public and all members of the healthcare team about proper stroke care. Surprisingly, only 20%-30% of all hospitals have stroke teams in place. To bring stroke care into the 21st century, this deficiency must be addressed and additional treatment agents such as neuroprotective medications need to be approved.
Related Concept Videos
01:21Planning Nursing Care I
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:23Atherosclerosis IV: Nursing Management